Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 3Genitourinary 2Other neoplasm 1Other hematologic neoplasm 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 2

Interventions

Prednisone 122Docetaxel 118enzalutamide 101pembrolizumab 96Sunitinib 86Leuprolide 84Abiraterone Acetate 83Nivolumab 78Gemcitabine 76bicalutamide 54Radiotherapy 54Goserelin 54Bevacizumab 54Cisplatin 52Magnetic Resonance Spectroscopy 49Everolimus 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 46Sorafenib 40Carboplatin 40Paclitaxel 37Radiosurgery 36atezolizumab 35abiraterone 33pazopanib 32cabozantinib 32Ipilimumab 32Axitinib 30Cyclophosphamide 29Androgen Antagonists 29Radiation 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Lovastatin × Genitourinary × Clear all
NCT01478828 2019-03-27

Pre-Prostatectomy Lovastatin on Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Terminated
2 enrolled 4 charts
Genitourinary

Prostatic Neoplasms

NCT00580970 2016-11-18

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

Virginia Commonwealth University

Phase 2 Completed
73 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡